Search research articles
Contact Us
Filters
Showing results (161-170 of 182) with videos related to
Page
of 19
Sort By:
The Lancet Regional Health. Western Pacific
|
October 28, 2025
Psychotropic medication consumption before and after onset of COVID-19 pandemic in 91 countries and regions: a time-series analysis
Caige Huang, Yu Yang, Yue Wei, et al.
The Lancet. Neurology
|
July 10, 2019
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
Diego Cadavid, Michelle Mellion, Raymond Hupperts, et al.
JAMA Psychiatry
|
January 25, 2023
Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic
Hao Luo, Wallis C Y Lau, Yi Chai, et al.
Nature Cell Biology
|
July 6, 2023
Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability
Vincent Gaggioli, Calvin S Y Lo, Nazaret Reverón-Gómez, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
February 13, 2025
Mass cytometric analysis of circulating monocyte subsets in a murine model of diabetic gastroparesis
Shefaa AlAsfoor, Erik Jessen, Suraj R Pullapantula, et al.
Journal of the American College of Cardiology
|
April 15, 2026
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus
Fan Bu, Ruopeng Wu, Anna Ostropolets, et al.
The Lancet. Psychiatry
|
September 6, 2024
Psychotropic drug prescribing before and during the COVID-19 pandemic among people with depressive and anxiety disorders: a multinational network study
Hao Luo, Yi Chai, Sijia Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2026
Selinexor Plus Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis: Phase 3 SENTRY Trial
Prithviraj Bose, Haris Ali, Haifa Kathrin Al-Ali, et al.
American Journal of Hematology
|
December 9, 2021
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study
Sosana Delimpasi, Maria Victoria Mateos, Holger W Auner, et al.
Plos Medicine
|
December 5, 2024
Rare but elevated incidence of hematological malignancy after clozapine use in schizophrenia: A population cohort study
Yuqi Hu, Le Gao, Lingyue Zhou, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 182) with videos related to
Sort By:
Page
of 19
The Lancet Regional Health. Western Pacific
|
October 28, 2025
Psychotropic medication consumption before and after onset of COVID-19 pandemic in 91 countries and regions: a time-series analysis
Caige Huang, Yu Yang, Yue Wei, et al.
The Lancet. Neurology
|
July 10, 2019
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
Diego Cadavid, Michelle Mellion, Raymond Hupperts, et al.
JAMA Psychiatry
|
January 25, 2023
Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic
Hao Luo, Wallis C Y Lau, Yi Chai, et al.
Nature Cell Biology
|
July 6, 2023
Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability
Vincent Gaggioli, Calvin S Y Lo, Nazaret Reverón-Gómez, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
February 13, 2025
Mass cytometric analysis of circulating monocyte subsets in a murine model of diabetic gastroparesis
Shefaa AlAsfoor, Erik Jessen, Suraj R Pullapantula, et al.
Journal of the American College of Cardiology
|
April 15, 2026
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus
Fan Bu, Ruopeng Wu, Anna Ostropolets, et al.
The Lancet. Psychiatry
|
September 6, 2024
Psychotropic drug prescribing before and during the COVID-19 pandemic among people with depressive and anxiety disorders: a multinational network study
Hao Luo, Yi Chai, Sijia Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2026
Selinexor Plus Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis: Phase 3 SENTRY Trial
Prithviraj Bose, Haris Ali, Haifa Kathrin Al-Ali, et al.
American Journal of Hematology
|
December 9, 2021
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study
Sosana Delimpasi, Maria Victoria Mateos, Holger W Auner, et al.
Plos Medicine
|
December 5, 2024
Rare but elevated incidence of hematological malignancy after clozapine use in schizophrenia: A population cohort study
Yuqi Hu, Le Gao, Lingyue Zhou, et al.
Page
of 19